Chief Legal Officer of $AFRM sells 57,102 shares in insider sale

Katherine Adkins, the Chief Legal Officer of $AFRM, recently made headlines by selling 57,102 shares of the company, totaling an estimated $4,012,557 in revenue. This transaction represented about 33.7% of Adkins’ holdings in this particular class of $AFRM stock, leaving her with 112,467 shares after the sale. The details of this sale were disclosed in a recent filing with the Securities and Exchange Commission (SEC).

Over the past six months, insiders at $AFRM have been actively involved in trading the company’s stock. Among these transactions, there have been 26 instances of insider trading, with all 26 involving sales of shares and no purchases. In addition to Katherine Adkins, other notable insiders who have sold shares include Keith Rabois, Chief Financial Officer Robert O’Hare, Christa S Quarles, and Noel Bertram Watson.

Meanwhile, on the institutional front, there has been significant activity surrounding $AFRM stock. Institutional investors have been actively adjusting their portfolios, with 263 investors adding shares while 239 decreased their positions in the most recent quarter. Some of the notable moves include Citadel Advisors LLC adding 2,675,696 shares, Price T Rowe Associates Inc /MD/ adding 2,657,074 shares, and Coatue Management LLC removing 2,633,442 shares from their portfolio.

Analysts on Wall Street have also been closely monitoring $AFRM, with 12 firms issuing buy ratings and none issuing sell ratings in recent months. Some of the recommendations include an “Overweight” rating from Barclays, a “Buy” rating from Truist Securities, and a “Market Outperform” rating from JMP Securities.

In terms of price targets, several analysts have provided their projections for $AFRM. In the last six months, 14 analysts have offered price targets, with a median target of $65.5. Notable targets include a $75.0 target price set by Daniel Perlin from RBC Capital, an $80.0 target price set by Ramsey El-Assal from Barclays, and a $58.0 target price set by Matthew Coad from Truist Securities.

It is important to note that the information presented in this article is based on public data and is not intended as financial advice. Investors are advised to conduct their own research and consult with financial professionals before making any investment decisions.